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Critically ill babies are a high-risk group susceptible to neonatal acute kidney injury (nAKI) which has emerged as an independent risk factor for morbidity and mortality. 
The kidneys of the newborn are highly susceptible to nAKI due 
to the interplay between several vasoactive agents and hormones, 
leading to a low glomerular filtration rate (GFR), high renal 
vascular resistance, high plasma renin activity, and decreased 
intercortical perfusion. The incidence of nAKI in developing 
countries has been reported in the range from 10.8% to 41% in 
newborns admitted to the neonatal unit [1,2].
There are a number of challenges in the diagnosis and 
staging of nAKI. Measurement of urine output (UO) in 
neonates is difficult, and moreover, non-oliguric renal failure 
is a common entity in this age group making oliguria difficult 
to interpret [3,4]. Serum creatinine (SCr) measurements 
immediately after birth are influenced by maternal creatinine 
levels. With time, maturational renal changes impose a barrier to 
creatinine [5]. The proposed diagnostic classification systems  
for nAKI are mostly based on functional abnormalities in SCr 
and UO. The neonatal risk, injury, failure, loss, and end-stage 
kidney disease (nRIFLE) criteria proposed UO as a parameter to 
stage nAKI [6]. In 2013, the Kidney Disease: Improving Global 
Outcomes (KDIGO) clinical practice guidelines workgroup 
published a definition that combined aspects of both SCr and 
UO to provide a single tool for use in both research and clinical 
practice [7].
In India, perinatal asphyxia and neonatal sepsis contribute to 
53.0% and 10.6% of neonatal deaths, respectively [8]. Both sepsis 
and asphyxia compromise renal perfusion, and consequently, 
these neonates are at a higher risk of developing nAKI [9-12]. 
This study aims to estimate the hospital-based incidence of nAKI 
in septic and asphyxiated neonates, describe their clinical profile 
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and outcome, and compare the two classifications – nRIFLE and 
neonatal modified KDIGO for their agreement.
MATERIALS AND METHODS
This was a prospective cohort study conducted in a tertiary care 
neonatal intensive care unit (NICU) over 14 months. Assuming 
a prevalence of AKI in sepsis and asphyxia of 40% from the 
previous studies, a sample size of 90 was arrived at. A total of 90 
consecutive neonates (inborn and outborn) admitted to the NICU 
fulfilling the diagnosis of sepsis or perinatal asphyxia during the 
first 28 days of life were included in the study. Neonates in whom 
UO measurement was unsuccessful, neonates with a congenital 
abnormality of the kidney or urinary tract, undergoing surgery 
and those who had both perinatal asphyxia and sepsis were 
excluded from the study. The Institutional Ethics Committee 
approval was sought and informed consent taken from the parents 
before enrolling the neonate.
A neonate was diagnosed with sepsis if two of five parameters 
of the sepsis screen were positive (septic screen comprises 
total leukocyte count <5000, low absolute neutrophil count 
as per Manroe’s chart for term and Mouzinho’s chart for very 
low birth weight (VLBW) infants, immature/total neutrophil 
ratio >0.2, C-reactive protein >1 mg/dL, and micro-erythrocyte 
sedimentation rate >15 mm in the 1st h) or if a positive blood 
culture was obtained, in a clinically suspected case [13]. Perinatal 
asphyxia was diagnosed if the Apgar score was <6 at 5 min of 
life and/or the umbilical arterial blood pH at birth was <7.0 [14].
Enrolled neonates were screened for nAKI on day 3 of life or 
at admission, whichever was later. Clinical profile of all enrolled 
neonates was noted. UO was measured daily using diaper weights 
and condom catheter bag/neonatal uro-bag when applicable as 
per NICU protocol, and calculations were made 6 hourly. The 
dry diaper weight was deducted from the total weight of each 
wet diaper to arrive at the weight of urine in grams, which was 
numerically equal to the volume. In case, stool and urine were 
found to be mixed in the diaper, a constant value of 15 g was 
subtracted from the total diaper weight to correct for the stool 
weight. Catheterization was not done to obviate the risk of 
introducing infection.
SCr measurement, using modified Jaffe’s kinetic method, 
was performed on the day of recruitment and once every 48 h 
until 7 days of recruitment. In neonates with established nAKI, 
the interim values of creatinine were recorded during therapy, 
hospital stay, and at discharge. If the baby’s clinical condition was 
improving and the first and second creatinine measurements were 
normal, the third was deferred. To interpret SCr at recruitment 
and at discharge, a reference table was used [15]. Staging was 
done using both nRIFLE and modified KDIGO classifications, as 
shown in Tables 1 and 2. The KDIGO SCr criterion was used as 
the standard against which the other two criteria were compared.
Once nAKI was diagnosed, the neonates were managed 
according to the standard protocol. Babies were followed up 
during hospital stay for UO, clinical status, and therapeutic 
interventions. The clinical outcome in terms of recovery and 
discharge, discharge against medical advice (DAMA), or death 
was documented.
The number of neonates developing nAKI per 1000 septic 
and asphyxiated neonates was computed to calculate the 
incidence rate. The clinical and demographic details of neonates 
developing nAKI were reported using number and percentages. 
The Chi-square test was used to test the association of various 
risk factors with nAKI. To evaluate the agreement between the 
two mentioned criteria to stage nAKI, Pearson Chi-square and 
Kappa statistics were undertaken, and p<0.05 was considered 
statistically significant. All analyses were done using SPSS 
version 20 software.
RESULTS
Of the 90 neonates, 62 were diagnosed with sepsis and 28 were 
diagnosed with perinatal asphyxia. The demographic data are 
summarized in Table 3.
A total of 22 neonates developed nAKI (13 in sepsis and 9 in 
perinatal asphyxia) during the course of the study with a hospital-
based incidence in neonatal sepsis and perinatal asphyxia being 
145 and 464/1000 neonates, respectively, making an overall 
incidence in the study group as 244/1000 neonates. Oliguria was 
documented using both KDIGO (59.1%) and nRIFLE (81.8%) 
criteria.
As SCr has been the most widely used marker in most studies 
to stage nAKI, KDIGO SCr criteria were used as the standard 
of comparison for nRIFLE and KDIGO UO criteria. According 
Table 1: Neonatal RIFLE staging criteria [6]
Parameter SCr criteria UO criteria
Risk ? UO <1.5 mL/kg/h for 24 h
Injury ? UO <1.0 mL/kg/h for 24 h
Failure ? UO <0.7 mL/kg/h for 24 h 
or anuric for 12 h
Loss Persistent failure >4 weeks
End stage Persistent failure >3 months
Question mark is intended to mean uncertain thresholds. GFR: Glomerular filtration rate, 
eCCl: Estimated creatinine clearance, UO: Urine output, SCr: Serum creatinine
Table 2: Neonatal modified Kidney Disease: Improving Global 
Outcomes staging criteria [7]
Stage SCr Urine output
0 No change in SCr or increase <0.3 mg/dL ≥0.5 mL/kg/h
1 SCr increase ≥0.3 mg/dL within 48 h
OR
SCr increase ≥1.5–1.9×reference SCra 
within 7 days
<0.5 mL/kg/h 
for 6–12 h
2 SCr increase ≥2–2.9×reference SCra <0.5 mL/kg/h 
for ≥12 h
3 SCr increase ≥3 × reference SCra
OR
SCr ≥2.5 mg/dL
OR
Receipt of dialysis
<0.3 mL/kg/h 
for ≥24 h
OR
Anuria for 
≥12 h
aBaseline defined as the lowest previous. SCr value. SCr: Serum creatinine
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to KDIGO SCr, most of the neonates belonged Stage I AKI 
(77.8%) followed by Stage II. When nRIFLE was employed, the 
majority (45.4%) was found to be in Stage II followed by Stage I 
while KDIGO UO classified majority as having no AKI (40.9%) 
followed by Stage I AKI (Fig. 1).
Stage I AKI constituted a major proportion of neonates 
irrespective of gestational age with term, late preterm, early 
preterm, and extreme preterm babies having 83.30%, 80.00%, 
70.00%, and 100% Stage I AKI. Overall, the mortality in neonates 
with Stage I AKI was 41.18%, whereas in Stage II and Stage III 
AKI, the mortality was 100%.
In terms of the clinical outcome of neonates with nAKI, 
in-hospital mortality rate in septicemic neonates with nAKI was 
44.4% and 61.5% for asphyxiated babies. Further, the mortalities 
in nAKI affected neonates with Stage I, Stage II, and Stage III 
hypoxic-ischemic encephalopathy (HIE) were 0, 50.0%, and 
75.0%, respectively. The overall mortality was 54.6% in nAKI 
in contrast to 22.1% in neonates without nAKI. Stage-wise AKI 
mortality was reflective of an increasing mortality with worsening 
stage of AKI with 41% mortality in Stage I and 100% in Stages 
II and III AKI. The clinical recovery was observed in 40.91% 
who were eventually discharged, while 4.54% went DAMA. We 
observed that the nRIFLE and KDIGO classification systems 
used to stage nAKI had poor agreement, as described in Table 4.
DISCUSSION
The hospital-based incidence of nAKI in our study was 14.52% in 
sepsis and 46.43% in perinatal asphyxia. nAKI in neonatal sepsis 
was studied by Mathur et al., Salah et al., and Jagrawal et al. 
and they reported incidence ranging from 26% to 32% [12,16,17]. 
The higher incidence seen in these studies could be due to the 
different criteria for the diagnosis of AKI in terms of higher cutoff 
value of SCr. The incidence of nAKI in perinatal asphyxia in our 
study was similar to the incidence reported by other studies in 
India and the West, ranging from 38% to 64% [9,18,19].
The wide range of incidence may be explained by the 
difference in the criteria used to define AKI – while Selewski 
et al. studied 96 newborns undergoing therapeutic hypothermia 
using the neonatal modified KDIGO criteria reporting an nAKI 
incidence of 38%, and Kaur et al. studied 36 neonates using the 
AKIN criteria and reported a 41.7% incidence [9,18]. Gopal in 
their study of 50 asphyxiated neonates used oliguria as the marker 
to diagnose AKI and did not use SCr, which could explain the 
higher incidence of 64% that they found [19].
The male preponderance in nAKI found in our study was 
in agreement with Mortazavi et al. who reported a male:female 
ratio of 2:1 in their retrospective study of 6042 hospitalized 
newborns and by Salah et al. who studied nAKI in 250 septicemic 
babies [16,20]. However, this could be due to the higher proportion 
of males in the sample.
Table 3: Demographic details of the study population (n=90)
Parameter Category Sepsis, 
n (%)
Perinatal 
asphyxia, n (%)
Sex Male 42 (67.74) 14 (50.00)
Female 20 (32.26) 14 (50.00)
Birth weight ≥2500 g 9 (14.52) 6 (21.43)
≥1500–<2500 g 25 (40.32) 9 (32.14)
≥1000–<1500 g 24 (38.71) 8 (28.57)
<1000 g 4 (6.45) 5 (17.86)
Gestational 
age
<28 weeks 0 (0.00) 2 (7.14)
28–34 weeks 33 (53.22) 12 (42.86)
34–37 weeks 9 (14.52) 4 (14.28)
≥37 weeks 20 (32.36) 10 (35.71)
Figure 1: (a-c) Neonatal acute kidney injury based on different classification criteria (n=90)
a b
c
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Oliguria has been defined differently by different nAKI 
staging systems in use. In our study, with nRIFLE, 81.8% of 
neonates were oliguric, whereas 59.1% were found to be oliguric 
by modified KDIGO. The stark contrast in these values could 
be due to the high UO cutoff considered by the nRIFLE criteria 
(UO <1.5 mL/kg/h for 24 h). Most other studies define oliguria as 
UO <1 mL/kg/h (34) or UO <0.5 mL/kg/h but do not specify the 
duration to label a baby as oliguric [21]. Recent studies show that 
neonates have non-oliguric renal failure, making the traditional 
definition of oliguria an insensitive marker of AKI [22]. Hence, 
a higher cutoff may be required to detect oliguria in the neonatal 
population.
The majority of our AKI neonates belonged to Stage I when 
considered under KDIGO SCr criteria (77.8%), while according 
to KDIGO UO and nRIFLE, majority were in Stage II. Most 
other studies which have used the modified KDIGO criteria 
have been done on the subset of only VLBW infants or did 
not stage nAKI [23,24]. Koralkar et al., in their study, found a 
greater proportion of Stage III AKI, possibly because premature 
infants had lower GFR predisposing them to a higher degree 
of injury [24]. Other studies which looked at asphyxiated or 
septicemic neonates used criteria only to diagnose the presence 
of nAKI and did not stage it according to severity [9,12]. It is 
possible that modified KDIGO SCr criteria with its lower cutoffs 
pick up milder degrees of nAKI which reflects our finding of the 
majority being in Stage I as per KDIGO SCr.
The incidence of AKI in term and preterm neonates was 
comparable at 20.0% and 26.7%, respectively, though the severity 
increases with decreasing gestational age. These findings are in 
contrast to the findings of Mathur et al. and Mortazavi et al. 
who reported that preterm was less frequently accompanied by 
AKI than full-term neonates [12,20]. A study by Askenazi et al. 
also estimated AKI incidence in sick near-term/term infants 
to be similar to other neonatal cohorts [25]. In our study, the 
incidence of AKI in VLBW neonates was 25.00% and severity 
increased with decreasing birth weight. Studies done by Koralkar 
et al., Rhone et al., and Carmody et al. showed an AKI incidence 
between 18.0% and 39.8% [24,26,27].
In our study, the mortality rate was 44.4% in septicemic 
neonates with nAKI and 61.5% in asphyxiated neonates. The 
overall mortality in those with nAKI was significantly higher than 
those without nAKI. Recent studies have shown nAKI mortality 
in sepsis and asphyxia to be 56.5–72.2% and 7.6–71.4%, 
respectively [9,12,16,17,19,28]. Furthermore, the mortality rates 
in our study increased with decreasing gestational age and birth 
weight as shown in Table 5, and increasing stage of nAKI. The 
higher risk of mortality in VLBW infants has been explored 
by many studies [24,27]. However, the high rate of mortality 
in premature infants in our study could reflect the lesser renal 
reserve they have and lower GFR at birth. This was in accordance 
to the study done by Stojanovic et al. [29]. Askenazi et al. also 
found that a much higher proportion of Stage III nAKI was found 
in children who died (19.1%) as compared to those who survived 
(6.3%) [25].
Although studies have employed nRIFLE or modified KDIGO 
criteria separately to stage nAKI, none have compared them in a 
single study. While nRIFLE entirely omits SCr and uses only UO 
as a tool to stage nAKI, modified KDIGO uses a combination of 
the two. The poor agreement between the KDIGO SCr, KDIGO 
UO, and nRIFLE UO could indicate that substituting one for the 
other is not feasible. KDIGO and, less frequently, nRIFLE have 
been employed by different studies but have not been compared 
for their feasibility, for which larger studies are required.
Our study was limited by a small sample size and larger 
multicenter studies are required to establish their individual use 
in the neonatal population. In addition, inherent inaccuracies 
may exist in UO measurement by diaper weight, which was the 
method used in our study.
CONCLUSION
AKI in neonates is common in neonates with both sepsis and 
perinatal asphyxia. Staging nAKI may be challenging, but early 
diagnosis is essential, especially in small and/or premature 
neonates as it is associated with significant mortality in these 
babies. Oliguria may still be a useful indicator of nAKI and 
considering higher cutoffs as per the nRIFLE criteria may help 
pick up milder stages.
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